The Association representing the patients will file a complaint against X. It wants to obtain an explanation on the change in formula of Levothyrox.
The case will be settled in court. The French Association of Thyroid Patients (AFMT) has announced its intention to file a complaint against X with the public health center of the Paris court.
Represented by Marie-Odile Bertella-Geffroy, she should begin the process during the week of September 11. In question, the modification of the composition of Levothyrox, a drug used to treat hormonal imbalances. It would be the cause of heavy side effects.
The objective is clear: to obtain satisfactory explanations from the manufacturer, Merck, and the health authorities. “These drugs are very sensitive and we cannot, without long and scientific information or procedure, change the formulation,” explains lawyer Marie-Odile Berthella-Geffroy. In fact, many patients have complained of side effects after replacement one of the excipients of Levothyrox.
A study launched
With this complaint, the AFMT follows in the footsteps of a patient who attacked the Merck lab. Filed in Mougins (Alpes-Maritimes), it accuses the manufacturer of “endangering the lives of others. “
The accused tried to defend themselves but without convincing the patients. During a press conference, the Minister of Health, Agnès Buzyn, recognized a situation of “crisis” related to the change of formula of this treatment administered in the thyroid disorder. While refusing to qualify the situation as a health scandal.
“These effects are significant, but they do not endanger people’s lives,” she said. It is important that patients talk to their doctor about it, but that they do not stop their treatment because then they would put themselves in danger ”. A pharmacovigilance study was nevertheless launched, in order to collect all the reports. The marketing of generic versions was also mentioned.
.
